Sagimet Biosciences, Inc. (SGMT)
8.03
-0.57
(-6.63%)
USD |
NASDAQ |
Apr 30, 16:00
8.08
+0.05
(+0.62%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly) : 116.48M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Omeros Corp. | 325.63M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.101M |
| Shareholders Equity (Quarterly) | 111.38M |
| Debt to Equity Ratio | 0.0007 |
| Current Ratio | 22.76 |
| Net Debt Paydown Yield | 0.00% |